An ISO 31000-Based Risk Matrix for Risk Management in Anticancer Drug Prescription, Compounding, and Administration...

Area of Science:

• Oncology
• Healthcare Management
• Patient Safety

Background:

• Lung cancer patients undergoing anticancer drug therapy in Day Hospitals (DH) face potential patient safety and organizational risks.
• Identifying and mitigating these risks is crucial for optimizing care delivery.

Purpose of the Study:

• To identify and reduce risks impacting patient safety and organizational aspects during lung cancer therapy in a Day Hospital setting.
• To implement and assess the effectiveness of risk mitigation strategies.

Main Methods:

• A modified Delphi approach was used by a multidisciplinary team to identify care processes, activities, and risk factors.
• A 5x5 semi-quantitative ISO 31000 risk matrix assessed harm severity and occurrence probability.
• Improvement actions were identified and adopted to reduce risks.

Main Results:

• 19 potential risks were identified, with 10 affecting patient safety and 9 impacting the organization.
• Highest organizational risks included DH outpatient visits and drug administration.
• Post-mitigation, high-level organizational risks decreased from 44.4% to 0.0%, and moderate patient safety risks reduced from 50.0% to 10.0%.

Conclusions:

• The ISO 31000 risk management framework effectively improved both organizational and safety objectives in lung cancer Day Hospital care.
• This systematic approach enhances the overall quality and safety of oncology patient management.